294 related articles for article (PubMed ID: 27991929)
1. miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-κB feedback loops.
Wang T; Xu X; Xu Q; Ren J; Shen S; Fan C; Hou Y
Oncogene; 2017 Jun; 36(23):3240-3251. PubMed ID: 27991929
[TBL] [Abstract][Full Text] [Related]
2. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
3. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer.
Zou F; Mao R; Yang L; Lin S; Lei K; Zheng Y; Ding Y; Zhang P; Cai G; Liang X; Liu J
FEBS J; 2016 Apr; 283(8):1438-52. PubMed ID: 26859226
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
[TBL] [Abstract][Full Text] [Related]
6. Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling.
Zhao H; Pan WM; Zhang HH; Song Y; Chen J; Xiang Y; Gu B; Li SZ; Du RL; Zhang XD
Cell Death Dis; 2019 Apr; 10(4):304. PubMed ID: 30944312
[TBL] [Abstract][Full Text] [Related]
7. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3.
Zhang Q; Yu K; Cao Y; Luo Y; Liu Y; Zhao C
Life Sci; 2021 Apr; 270():119071. PubMed ID: 33515562
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑449a is a potential predictor of colitis‑associated colorectal cancer progression.
Feng Y; Dong YW; Song YN; Xiao JH; Guo XY; Jiang WL; Lu LG
Oncol Rep; 2018 Sep; 40(3):1684-1694. PubMed ID: 30015944
[TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling.
Kim YH; Kim JH; Kim BG; Lee KL; Kim JW; Koh SJ
J Gastroenterol Hepatol; 2019 Mar; 34(3):544-551. PubMed ID: 30378164
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-19a targeting TNF-α in mediating ulcerative colitis.
Chen B; She S; Li D; Liu Z; Yang X; Zeng Z; Liu F
Scand J Gastroenterol; 2013 Jul; 48(7):815-24. PubMed ID: 23795660
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of miRNAs regulating NF-κB and STAT3 crosstalk during colitis-associated tumorigenesis.
El-Daly SM; Omara EA; Hussein J; Youness ER; El-Khayat Z
Mol Cell Probes; 2019 Oct; 47():101442. PubMed ID: 31479716
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression.
Shen Z; Zhou R; Liu C; Wang Y; Zhan W; Shao Z; Liu J; Zhang F; Xu L; Zhou X; Qi L; Bo F; Ding Y; Zhao L
Cell Death Dis; 2017 Dec; 8(12):3213. PubMed ID: 29238068
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer.
Huang L; Wang X; Wen C; Yang X; Song M; Chen J; Wang C; Zhang B; Wang L; Iwamoto A; Wang J; Liu H
Sci Rep; 2015 Aug; 5():13350. PubMed ID: 26302825
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.
Zhang P; Pan Y; Sun J; Pan G
Int J Exp Pathol; 2021 Jun; 102(3):163-171. PubMed ID: 33983643
[TBL] [Abstract][Full Text] [Related]
19. Elevated MMP10/13 mediated barrier disruption and NF-κB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice.
Tang K; Wu Z; Sun M; Huang X; Sun J; Shi J; Wang X; Miao Z; Gao P; Song Y; Wang Z
Cancer Lett; 2022 Mar; 529():53-69. PubMed ID: 34979166
[TBL] [Abstract][Full Text] [Related]
20. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
